Microparticles in Scuba Divers With Decompression Sickness
Completed
Conditions studied: Decompression Sickness, Dysbarism
In brief
The investigators hypothesize that membrane microparticles (MPs) are liberated into the blood stream in response to decompression stress and that certain MPs characteristics initiate inflammatory responses that contribute to the clinical syndrome the investigators call decompression sickness. The research goal is to evaluate the number, type and time-course for elevations in MPs in sport SCUBA divers who present for treatment of decompression sickness. Blood samples are to be taken from consenting patients before and after they undergo treatment for decompression sickness and at a follow-up clinic visit from 1 to 3 weeks later (three samples total).
Key facts
- Study ID
- NCT01587209
- Run by
- University of Pennsylvania
- People needed
- 1
- Starts
- 2011-08-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2016-08-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who are given the diagnosis of decompression sickness will be offered entry into this study
You may not qualify if…
- Inability to provide informed consent
Where it is running
- University of Pennsylvania — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.